Aug 2026· Nature Neuroscience· Vol 29, pp. 2324 - 2340· 1 citation· 96 references
Medicine
TL;DR
A reproducible human three-dimensional brain tissue model with neurons, astrocytes and microglia, replicating in-vivo-like maturation and enabling the study of Alzheimer’s disease-relevant perturbations and drug responses is developed.
Abstract
Stem-cell-based in vitro models offer promising potential to elucidate human brain cell functions and interactions, but limitations in reproducibility, maturation and cell-type diversity persist. Especially, prolonged incorporation of mature microglia and studies of neuroinflammation have proven challenging. Here, we developed a human induced pluripotent stem cell-based three-dimensional cortical brain tissue model (3BTM) containing neurons, astrocytes and microglia with high reproducibility, maturity and viability. 3BTMs show morphological, functional and proteomic maturation of all cell types, leading to high similarity to their in vivo counterparts. Incorporated microglia survive for over 6 months and display mature morphology, functions and gene expression. Importantly, when engineered to model Alzheimer’s disease pathology, 3BTMs recapitulate key disease hallmarks, including amyloid deposition, increased phospho-tau levels and neuroinflammation, with microglia shifting their transcriptional landscape to disease-relevant signatures. Treatment of Alzheimer’s disease 3BTMs with anti-Aβ immunotherapy cleared deposits and largely reversed disease signatures in glia. Together, our microglia-containing model provides a platform for studying physiological and pathological states of human brain tissue. Klimmt, Cardoso Gonçalves et al. developed a reproducible human three-dimensional brain tissue model with neurons, astrocytes and microglia, replicating in-vivo-like maturation and enabling the study of Alzheimer’s disease-relevant perturbations and drug responses.
An overview of modern techniques for generating 2-dimensional monocultures and co-cultures, 3-dimensional organoids and assembloids, and chimeras containing hiPSC-derived microglia and astrocytes is provided.
Rose Summers, D. Quang, Noah R. Johnson· International Journal of Mol...· 0 citations
A co-maturation protocol that robustly generates glutamatergic neuronal networks containing hiPSC-derived microglia and induced the typical ramified microglia morphology and characteristic microglia-neuron interactions is presented.
A. Mordelt, I. Schuurmans, Nicky Scheefhals et al.· Stem Cell Reports· 0 citations
HAMSC-EVs exert robust anti-inflammatory and neuroprotective effects in both murine and human AD models, improving cognition, modulating glial activation, and restoring synaptic integrity, and highlight the translational potential of intranasal hAMSC-EVs as an adjuvant therapeutic strategy targeting neuro inflammation...
Andrea Papait, F. Natale, A. Silini et al.· Translational Neurodegenerat...· 0 citations
This review critically evaluates the use of iPSC‐derived brain organoids as a disease‐focused approach to study neuroinflammation, neurodegeneration, infection, and aging.
Bishwa R. Pokharel, Abigail Dickerson, Sanjana G. Shenoy et al.· European Journal of Neurosci...· 0 citations
It is shown that a disease-associated microglial subtype, characterized by elevated GPNMB expression and enriched for polygenic AD risk, expands with AD pathology and shows increased phagocytic activity, and MITF is identified as an upstream regulator required to maintain this microglial state.
Donghoon Lee, James M. Vicari, Christian Porras et al.· Nature Genetics· 1 citation
An enhanced human induced pluripotent stem cell (hiPSC)-derived cerebral organoid (CO) platform optimized to mitigate core hypoxia for over 200 days enables longitudinal modeling of neural-immune crosstalk in age-related and neuroinflammatory CNS disorders.
J. Kocot, S. Pradhan, D. Maric et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.